结合“改良FIGO预后评分系统”治疗妊娠滋养细胞肿瘤95例临床分析

Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia of 95 cases

目的分析、评价妊娠滋养细胞肿瘤2002年国际妇产科联盟"改良FIGO预后评分标准"的应用价值。方法选择恶性滋养细胞肿瘤患者95例,根据2002年FIGO解剖分期和改良FIGO评分系统进行解剖分期和预后评分,与之前未进行预后评分者进行治疗效果比较。结果按照FIGO解剖分期进行治疗的86例患者获得完全缓解率73.25%。而按照FIGO解剖分期和预后评分系统治疗的95例患者完全缓解率86.32%。结论结合改良FIGO预后评分标准选择分层次个体化治疗方案效果好于按照FIGO解剖分期治疗方案。

[ Objective ] To assess malignant trophoblastic neoplasia with the standards of the clinical stage and prognostic factor scoring system. [Methods] 95 cases who had complete data were selected. They were given anatomical staging and prognosis score. The efficacy of treatment was compared, according to 2000 FIGO stage and score standard. [ Results ] 73.25% of the 86 patients who were treated in accordance with the clinical stage achieved complete remission, and 86.32% of the 95 patients who were treated according to FIGO staging and prognostic scoring system achieved complete remission after. [ Conclusion ] The treatment outcome in accordance with the standard FIGO was better than that of the anatomical staging treatment. Treatment should also refer to the anatomical stage and prognostic score and the effective use of integrated treatment.